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Background: Hypokalemia induced by diuretic abuse is a life-threatening emergency.
Case presentation: A 22-years-old female nurse with a body mass index 18 suffered from myalgias, vomiting and
diarrhea. Blood tests revealed hypokalemia with a lowest value of 1.1 mmol/l, moderate hyponatremia, metabolic
alkalosis, mild renal insufficiency and creatinphosphokinase-elevation. Since hypokalemia and alkalosis were
unexplained, she was asked for diuretic-intake. She confessed that she has taken 250 mg furosemide/day for the
last 4 months to improve the shape of her muscles. Furosemide tablets were given to her by a physician attending
the gym where she exercised. After electrolyte substitution, laboratory abnormalities regressed and no cardiac
arrests were observed. Psychiatric investigation diagnosed an adjustment disorder.
Conclusion: Furosemide abuse has to be considered even in underweight individuals, especially if they have a
psychiatric instability or work in health care institutions.
Keywords: Furosemide, Hypokalemia, RhabdomyolysisBackground
Chronic abuse of furosemide as cause of hypokalemia
has been repeatedly reported [1-5]. Extreme furosemide-
induced hypokalemia with a serum potassium level of
1.1 mmol/l, is rare and associated with life-threatening
cardiac arrest and rhabdomyolysis [6-8]. Typically,
furosemide-induced hypokalemia is characterized by
hypernatremia, hypocalcemia, hypomagnesemia, high
urine calcium creatinine ratio, high urine sodium ex-
cretion and high urine calcium/creatinine ration.
Furosemide-induced hypokalemia may also present
without these electrolyte abnormalities and only be
detected by the history, as shown by the following case.
Case presentation
A 22-years-old female nurse was admitted because of
myalgias since 10 days, vomiting and diarrhea since
4 days, and generalized weakness and dizziness since
3 days. She had a history of Raynaud’s disease and of a
restless leg syndrome since 9 years. She reported to take
no medication against these disorders. The family his-
tory was negative for renal and muscle disease. Clinical* Correspondence: claudia.stoellberger@wienkav.at
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reproduction in any medium, provided the orexamination showed an alert young female with 160 cm
length and 46 kg weight (Body mass index 18). Blood
pressure was 115/80 mm Hg and the respiratory rate 12/
min. No abnormalities were found at clinical examination.
There were no abnormalities in the skin turgor. Blood
tests revealed severe hypokalemia with a lowest value of
1.1 mmol/l, moderate hyponatremia, metabolic alkalosis,
mild renal insufficiency and creatinphosphokinase (CK)
elevation (Table 1). Urine electrolytes on day 2 showed a
decreased excretion of potassium (9 mmol/l, normal range
20–80 mmol/l) and sodium (29 mmol/l, normal range 54–
150 mmol/l). Thyroid function tests were normal. The elec-
trocardiogram showed ST-segment abnormalities and a
prolonged QT interval (Figure 1). Since the severe hypokal-
emia and alkalosis were not explained by the gastrointes-
tinal problems, she was asked for intake of diuretics even
12 hours after admission. She confessed that she has taken
250 mg furosemide/day for the last 4 months in order to
improve the shape of her muscles and to have a more
brawny appearance. She had received the tablets from a
physician who attended the same gym where she exercised.
The patient was diagnosed as suffering from furosemide-
induced hypokalemia and rhabdomyolysis. Parenteral and
enteral substitution of potassium, sodium and magnesium
was started. The serum electrolyte levels normalized withind. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Laboratory findings
Parameter Reference value Day 1 Day 1 Day 2 Day 2 Day 3 Day 3 Day 5 Day 7 Day 8 Day 15
12:02 22:58 05:47 21.38 07:42 18:10 09:45 10:42 08:08 12:21
BUN 9.0-20.0 mg/dl 25 21 21 NM 12 9 4 6 8 14
Creatinine −1.1 mg/dl 1.64 1.15 NM NM 0.87 1.00 0.74 0.80 0.84 0.81
GFR >90 ml/min/1.73 m 42 63 NM NM 87 74 104 95 90 94
Sodium 136.0-145.0 mmol/l 130 129 132 132 138 136 137 140 140 139
Potassium 3.3-5.1 mmol/l 1.1 1.6 1.5 1.4 1.7 2.8 4.5 5.4 4.9 5.0
Chloride 98.0-106.0 mmol/l 90 92 97 98 101 97 100 NM NM 99
Calcium 2.1-2.7 mmol/l 2.66 2.0 2.0 2.0 2.1 2.0 2.1 NM NM 2.8
pH 7.33-7.42 7.549 7.514 7.468 7.454 7.357 7.453 7.467 NM NM 7.371
HCO3
- 22-26 mmol/l 31.4 28.6 29.0 28.4 25.3 30.9 33.3 NM NM 29.0
PCO2 38-42 mmHg 36.1 34.2 40.9 42.3 52.1 48.0 35.7 NM NM 57.0
CK −144.0 U/l 15966 13143 11570 NM 9882 12043 5703 1867 1070 102
Leukocytes 4.0-9.0/nl 18.1 NM NM NM 9.5 8.9 NM NM 5.5 5.9
Erythrocytes 4.0-5.2/pl 5.19 NM NM NM 3.28 3.48 NM NM 3.54 3.55
Hemoglobin 12.0-16.0 g/dl 16.6 NM NM NM 10.4 11.2 NM NM 11.4 12.1
Hematocrit 38.0-48.0% 42.7 NM NM NM 27.8 29.6 NM NM 35.0 35.2
GFR = glomerular filtration rate, estimated according the Modified Diet in Renal Disease formula; CK = Creatinphosphokinase.
Figure 1 Electrocardiographic recordings on day 1 (A), day 3 (B) and day 7 (C) showing ST abnormalities and QT prolongation on days
1 and 3 which normalized on day 7. The QTc according to Bazett’s formula was 670 msec (day 1), 405 msec (day 3) and 401 msec (day 7).
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weeks and the myalgias regressed. A psychiatric investiga-
tion excluded suicidality, depression or eating disorder,
diagnosed an adjustment disorder and recommended psy-
chotherapy. Her heart rhythm was monitored during 7 days
and did not show any arrhythmias. Echocardiography did
not disclose any cardiac abnormalities, and the electrocar-
diogram normalized (Figure 1). After 7 days she left the
hospital and returned for blood tests after one week.
Discussion
This patient with severe hypokalemia is interesting for the
following reasons: It is extremely rare that serum potassium
levels decrease below 2 mmol/l and that such low levels are
tolerated without cardiac arrests. Previous reports show
that severe hypokalemia is associated with cardiac arrests
and the necessity for cardiopulmonary resuscitation [6].
That our patient did not develop any arrhythmia despite se-
vere hypokalemia may be explained by her healthy heart as
demonstrated by the normalization of electrocardiography
and normal echocardiographic findings, by the chronic de-
velopment of hypokalemia and, possibly, by unknown gen-
etic protective factors [9].
Furosemide-induced hypokalemia, also termed “Pseudo-
Bartter-Syndrome”, is found mainly in young females who
work in health-care institutions, like our patient, who may
have an easy opportunity to watch the impressive effect of
diuretics and have an easier access to the drugs than
people who work outside health-care institutions [1-5].
Motivation for surreptitious furosemide intake is the
intention to slim, to avoid edema or, like in our patient,
to change the shape of the body. Furosemide may be
taken also unknowingly as an undeclared component
of “health teas” and lead to hypokalemia [10]. Previous
reports indicate that extensive diagnostic measures
may be necessary to establish the diagnosis, thus our
experience to confront the patient early in the diagnos-
tic process with the suspicion of diuretic-intake seems
reasonable.
Neurologic manifestations of hypokalemia comprise
paralysis and rhabdomyolysis [11-13]. Rhabdomyolysis in
hypokalemia either remains asymptomatic or manifests
clinically with muscle pain, cramps and weakness. The
reason for rhabdomyolysis in hypokalemia is assumed to
be muscle ischemia. Physiologically elevated potassium,
for example due to exercise, causes vasodilatation and
thus increases the muscular blood flow [14]. In case of
hypokalemia, increase of serum potassium is hindered
resulting in relative ischemia, muscle cramps, and in
case of severe depletion, muscle necrosis and rhabdo-
myolysis [14]. Another pathomechanism may be
impaired myocyte metabolism or membrane dysfunc-
tion, resulting in muscle-cell breakdown or membrane
leakage [15].It remains unclear why our patient did not develop the
electrolyte abnormalities typical for furosemide-induced
hypokalemia. Her concomitant hyponatremia cannot be
explained by furosemide-intake since furosemide may
lead to hypernatremia. Probably, other so far unknown
factors may have contributed to hyponatremia. Unfortu-
nately, no urine chloride levels have been measured.
One would expect them to be elevated, which could
have been helpful in the patient’s workup if she had not
admitted diuretic intake.
Additionally it remains unknown whether she had a
predisposition to hypokalemia or rhabdomyolysis. Disor-
ders which may lead to hypokalemia like Gitelman syn-
drome, Bartter syndrome, Andersen-Tawil syndrome,
renal tubular acidosis or periodic hypokalemic paralysis
were excluded by the negative family history, the ab-
sence of a periodic occurrence and the absence of hypo-
magnesemia, hypocalcemia and acidosis [16,17].
Conclusions
This case shows that furosemide-induced severe hypo-
kalemia may present without cardiac arrest, may be sur-
vived without sequelae and may be accompanied by
transient rhabdomyolysis. Chronic furosemide abuse in
order to lose weight has to be considered even in under-
weight individuals, especially if they have a psychiatric
instability or work in health care institutions.
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